Results 101 to 110 of about 56,712 (295)

Silent Gastroesophageal Reflux Disease

open access: yesJournal of Neurogastroenterology and Motility, 2012
Gastroesophageal reflux disease (GERD) is defined as the presence of acid-reflux-related symptoms, or esophageal mucosal damage, caused by the reflux of gastric contents into the esophagus.1 The diagnosis of GERD can therefore be easily made by patients' complaint of typical (heartburn and regurgitation) and/or atypical acid-reflux-related symptoms ...
openaire   +4 more sources

The Growing Burden of Obesity: Addressing a Global Public Health Challenge

open access: yes
United European Gastroenterology Journal, EarlyView.
Patrizia Burra   +11 more
wiley   +1 more source

Mepolizumab Effectiveness in Severe Asthma With/Without Chronic Rhinosinusitis With Nasal Polyps: Real‐World Pooled Analysis

open access: yesAllergy, EarlyView.
MEPOLYP was a pooled analysis of 1037 patients with SAEP[±]CRSwNP. Mepolizumab was associated with a reduction in CSEs, OCS use, and BEC, and improved lung function and ACT score. Over 47% of patients fulfilled ≥ 3 clinical remission criteria. When compared, there was a 30.0% incremental benefit of mepolizumab in reducing CSEs for patients with SAEP ...
Florence Schleich   +14 more
wiley   +1 more source

Infant Acid‐Suppressant Medication, C. difficile Colonisation, and Childhood Body Mass Index in a Canadian Cohort

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim To determine relationships between paediatric use of acid‐suppressive medications (ASMs) (proton pump inhibitors (PPI) and histamine‐2 receptor antagonists (H2RA)) and preschool body mass index (BMI) and mediation by C. difficile colonisation. Methods ASMs were parent‐reported at age 3, 6 and 12 months in 1025 infants from the CHILD Cohort
Sarah L. Bridgman   +12 more
wiley   +1 more source

Clinical and Neurodevelopmental Characteristics of Paralogous Gain‐of‐Function Variants at GRIA2 p.Gly792 and GRIA3 p.Gly803

open access: yesClinical Genetics, EarlyView.
Key features of paralogous GRIA2 and GRIA3 gain‐of‐function variants. ABSTRACT GRIA‐related disorders arise from disease‐causing variants in GRIA1, GRIA2, GRIA3, or GRIA4 that encode α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid (AMPA)‐type glutamate receptors (AMPARs).
Emilie Sjøstrøm   +24 more
wiley   +1 more source

White–Sutton Syndrome: Insight of an Italian Cohort of 19 Subjects

open access: yesClinical Genetics, EarlyView.
New insights into White–Sutton syndrome with a collection of 19 Italian patients. Due to its complexity, we stress the importance of a systematic evaluation following the diagnosis and a thoughtful management of patients. Preliminary genotype–phenotype correlation analysis suggests the association between disruptive splicing variants and more severe ...
Anna Facchini   +14 more
wiley   +1 more source

The effect of dietary carbohydrate on gastroesophageal reflux disease

open access: yesJournal of the Formosan Medical Association, 2018
Background: Acid changes in gastroesophageal reflux with vary component in the food have less been studied, especially carbohydrate. We plan to clarify the effect of different carbohydrate density on low esophageal acid and reflux symptoms of patients ...
Keng-Liang Wu   +6 more
doaj  

Home - About - Disclaimer - Privacy